Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Sugammadex clinical trials

1 of 2 indexed Sugammadex trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Sugammadex: 2 US clinical trials tracked, 1 recruiting.

Sugammadex is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is University of California, Davis, running 1 of these trials.

Enrollment posture brief

Registry condition sugammadex

OPEN 1 | RECR 50% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Sugammadex (this)50%
Open-enrollment share among volume-matched conditions near Sugammadex

Sugammadex lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Sugammadex on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Sugammadex is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Sugammadex records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Choice of reversal agent (sugammadex or neostigmine [with muscaranic antagonist]) Drug
1 trials
Quantitative Neuromuscular Function Monitoring Device
1 trials

US sites by state

Facility locations filed on Sugammadex trials. A trial with sites in several states counts in each.

Massachusetts 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Sugammadex page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Sugammadex condition card totals 2 registered trials; most-linked intervention Choice of reversal agent (sugammadex or neostigmine [with muscaranic antagonist]); top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.